New Zealand markets closed

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
365.25+3.53 (+0.98%)
At close: 01:00PM EST
365.46 +0.21 (+0.06%)
After hours: 04:59PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
29,239,500
28,318,400
24,539,800
22,319,500
24,555,700
Cost of revenue
7,131,900
7,312,800
5,483,300
4,721,200
6,430,000
Gross profit
22,107,600
21,005,600
19,056,500
17,598,300
18,125,700
Operating expenses
Research development
7,188,400
7,025,900
6,085,700
5,595,000
5,307,100
Selling general and administrative
6,389,200
6,431,600
6,121,200
6,213,800
6,631,800
Total operating expenses
13,577,600
13,457,500
12,206,900
11,808,800
11,938,900
Operating income or loss
8,530,000
-
6,849,600
5,789,500
6,186,800
Interest expense
329,000
339,800
359,600
400,600
272,100
Total other income/expenses net
-1,695,800
-1,078,200
706,900
-203,400
-2,280,300
Income before tax
6,549,900
6,155,500
7,229,900
5,265,900
3,795,700
Income tax expense
516,700
573,800
1,036,200
628,000
563,700
Income from continuing operations
6,033,200
5,581,700
6,193,700
4,637,900
3,232,000
Net income
6,033,200
5,581,700
6,193,700
8,318,400
3,232,000
Net income available to common shareholders
6,033,200
5,581,700
6,193,700
8,318,400
3,232,000
Basic EPS
-
6.15
6.82
8.93
3.14
Diluted EPS
-
6.12
6.79
8.89
3.13
Basic average shares
-
906,963
907,634
931,059
1,027,721
Diluted average shares
-
911,681
912,505
935,684
1,033,667
EBITDA
-
8,042,900
8,913,400
6,899,100
5,676,800